Your browser doesn't support javascript.
loading
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Habringer, Stefan; Demel, Uta M; Fietz, Anne-Katrin; Lammer, Felicitas; Schroers, Roland; Hofer, Silvia; Bairey, Osnat; Braess, Jan; Meier-Stiegen, Anna Sofia; Stuhlmann, Reingard; Schmidt-Hieber, Martin; Hoffmann, Johannes; Zinngrebe, Bettina; Kaiser, Ulrich; Reimer, Peter; Möhle, Robert; Fix, Peter; Höffkes, Heinz-Gert; Langenkamp, Ulrich; Büschenfelde, Christian Meyer Zum; Hopfer, Olaf; Stoltefuß, Andrea; La Rosée, Paul; Blasberg, Henning; Jordan, Karin; Kaun, Stephan; Meurer, Anna; Unteroberdörster, Meike; von Brünneck, Ann-Christin; Capper, David; Heppner, Frank L; Chapuy, Björn; Janz, Martin; Schwartz, Stefan; Konietschke, Frank; Vajkoczy, Peter; Korfel, Agnieszka; Keller, Ulrich.
Affiliation
  • Habringer S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité (BIH), Berlin, Germany; German Cancer Cons
  • Demel UM; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité (BIH), Berlin, Germany.
  • Fietz AK; Institute of Biostatistics and Clinical Epidemiology, Charité - Universitätsmedizin, Berlin, Germany.
  • Lammer F; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schroers R; Department of Medicine, Hematology and Oncology, Ruhr University Bochum, Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany.
  • Hofer S; Division Medical Oncology Cantonal Hospital Luzern, Luzern, Switzerland; Department of Neurology, University Hospital Zürich, Zürich, Switzerland.
  • Bairey O; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel.
  • Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.
  • Meier-Stiegen AS; Department of Hematology, Oncology and Palliative Care, Department of Internal Medicine, Evangelisches Klinikum Bethel, Bielefeld, Germany.
  • Stuhlmann R; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St. Georg, Hamburg, Germany.
  • Schmidt-Hieber M; Department of Hematology and Oncology, Carl-Thiem-Klinikum Cottbus, Cottbus, Germany.
  • Hoffmann J; Pius-Hospital, University Medicine Oldenburg, Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Oldenburg, Germany.
  • Zinngrebe B; Department of Hematology, Oncology and Palliative Care, Department of Internal Medicine, Evangelisches Klinikum Bethel, Bielefeld, Germany.
  • Kaiser U; Medizinische Klinik II, St Bernward Krankenhaus, Hildesheim, Germany.
  • Reimer P; Department of Hematology, Medical Oncology and Stem Cell Transplantation, Kliniken Essen-Mitte, Essen, Germany.
  • Möhle R; Department of Internal Medicine II, Medical University Hospital, Tübingen, Germany.
  • Fix P; Onkologische Praxis Dr. med. Peter Fix, Jena, Germany.
  • Höffkes HG; Klinikum Fulda, Tumorklinik, Fulda, Germany.
  • Langenkamp U; Department of Internal Medicine, Medical Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, University of Rostock, 18057 Rostock, Germany.
  • Büschenfelde CMZ; 2. Med. Klinik, ViDia Christliche Kliniken, Karlsruhe, Germany.
  • Hopfer O; Department of Medicine I, Hospital Frankfurt (Oder), Frankfurt (Oder), Germany.
  • Stoltefuß A; Department of Hematology, Oncology and Palliative Care, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • La Rosée P; Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany; Klinik für Innere Medizin II, Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany.
  • Blasberg H; Hospital of Internal Medicine II, Hematology and Oncology, St. Georg Hospital Leipzig, Leipzig, Germany.
  • Jordan K; Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital, Potsdam, Germany.
  • Kaun S; Hematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
  • Meurer A; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Unteroberdörster M; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • von Brünneck AC; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Cluster of Excellen
  • Heppner FL; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Cluster of Excellen
  • Chapuy B; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Janz M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schwartz S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Berlin, Germany.
  • Konietschke F; Institute of Biostatistics and Clinical Epidemiology, Charité - Universitätsmedizin, Berlin, Germany.
  • Vajkoczy P; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Korfel A; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Berlin, Germany. Electronic address: ulrich.kel
Eur J Cancer ; 196: 113436, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38008033
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Central Nervous System Neoplasms / Hematopoietic Stem Cell Transplantation Limits: Aged / Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Central Nervous System Neoplasms / Hematopoietic Stem Cell Transplantation Limits: Aged / Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article Country of publication: